Cesar et al. established a cut-off >2.07 ng/mL to distinguish IPF and CTD-ILD patients from healthy controls and reported that CTD-ILD had higher serum MMP7 levels than IPF. The gene discussed is MMP7; the disease is idiopathic pulmonary fibrosis.